January 7, 2020
FDA: Class I recall of Medfusion 4000 Syringe Pumps
Editor's Note
The Food & Drug Administration (FDA) on December 19, 2019, identified the recall by Smiths Medical ASD, Inc of its Medfusion 4000 Syringe Pumps as Class I, the most serious.
The recall was initiated because of malfunctioning low-battery alarms, which may lead to an interruption of therapy.
The company has received 74 complaints related to the software. No injuries or deaths have been reported.
Distribution dates were September 27, 2019 to October 31, 2019.
Free Daily News
- UCSF surgeons spotlight innovation, perioperative research at national surgical conference
- FDA recalls affect surgical staplers, OR procedure kits, ultrasound systems used in hospitals
- C-sections linked to longer recovery, higher pain, sleep problems for new mothers
- AI model grades nursing procedures with near-human precision
- Study: Hospitals can safely cut low-value preop tests before routine surgeries
- New studies highlight opportunities to improve pediatric anesthesia safety, comfort
- Social and behavioral factors emerging as key predictors of recovery quality after surgery
- Hospitals being squeezed: Anesthesia workforce gaps, payer cuts threaten surgery access
- CDC layoffs cripple national injury and overdose tracking, leaving prevention efforts in doubt
- The Joint Commission makes nurse staffing a national performance goal for 2026
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement